Attorneys React To High Court's Gene Patent Ruling

Law360, New York (June 13, 2013, 11:04 PM EDT) -- The U.S. Supreme Court ruled unanimously Thursday that human genes cannot be patented, striking down Myriad Genetics Inc.'s patents on isolated DNA associated with an increased risk of breast cancer. Here, attorneys tell Law360 why the unanimous ruling is significant.

Bruce Abramson, Rimon PC

"While it does not comport to my understanding of the facts, it nevertheless represents proper judicial reasoning. I was heartened to see that the court did not delve into the public policy debates about either the exclusive ownership of therapeutic treatments or industry expectations. These are important issues, but they are not the purview of the courts....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS